Join our Community
Support ToI and remove all ads
Learn more
×

immune therapy

Dr. Nachum Nathan, left, and Prof. Ziv Shulman of Weizmann Institute of Science. (Courtesy)
May 26, 2026, 6:02 pm
In a world first, Israeli scientists find ‘memory’ B cells can target ovarian tumors
Immune cells not only remember viruses, but can also secrete tumor-fighting antibodies, say Weizmann Institute researchers; study could further development of cancer vaccines
By Diana Bletter
Elderly people work out with wooden dumb-bells in the grounds of a temple in Tokyo on September 17, 2012, to celebrate Japan's Respect-for-the-Aged-Day. (YOSHIKAZU TSUNO / AFP)
December 2, 2025, 7:23 am
Medical Holy Grail: Israeli researchers isolate elusive cells that may slow down aging
In peer-reviewed study, Prof. Alon Monsonego’s lab finds that ‘T helper’ blood cells, abundant in ‘super-centenarians’ in high-life-expectancy zone in Japan, may point the way to longevity
By Diana Bletter
Prof. Ayal Hendel, Bar Ilan University. Goodman Faculty of LIfe(Courtesy/Avishag Shaar-Yashuv)
September 2, 2025, 10:48 am
Israeli researcher joins EU cell therapy initiative for blood cancers and tumors
Bar-Ilan University scientist part of €8 million consortium to ensure accuracy in CAR-T cell therapy, an immunotherapy using CRISPR-Cas9, in European hospitals
By Diana Bletter
Israel Prize recipient Prof. Michal Schwartz blazes a trail toward anti-aging treatment through immune therapy (Courtesy of Weizmann Institute of Science)
January 14, 2025, 3:05 pm
Israeli scientist in peer-reviewed study: Immunotherapy treatment could slow aging process
Israel Prize winner Prof. Michal Schwartz says her team’s work fighting Alzheimer’s can lead to treatments that boost immune system to slow down deterioration in brain – and body
By Diana Bletter
The new Tel Aviv University 'GPS-guided' nanoparticle drug, in blue and green, around an immune cell. (courtesy of Tel Aviv University)
June 29, 2021, 10:28 am
New Israeli ‘GPS’ nano-drug busts inflammation, touted as antibody replacement
Nanoparticles, tested on mice and unveiled in peer-reviewed research, head straight to cells that are inflamed, and either ‘silence’ or edit the gene that is causing inflammation
By Nathan Jeffay
Gamida Cell's lab manager Noga Goudsmid-Rosenheimer at work, July 16, 2017 (Shoshanna Solomon/Times of Israel)
February 11, 2021, 11:33 am
Hope grows for blood cancer patients, as cell therapy firm’s key trial succeeds
Gamida Cell shares surge after results of key trial show flagship drug results in faster blood count recovery, fewer bacterial and viral infections after bone marrow transplants
By Shoshanna Solomon
Load More

Sign in or Join The Times of Israel Community

Sign in or Register

Paying ToI Community members are invited to comment on articles
Please use the following structure: example@domain.com
Or Continue with
By joining you agree to the terms and conditions
Register to continue
Or Continue with
Log in to continue
Sign in or Join The Times of Israel Community
Sign in or Register
Only ToI Community members can comment below articles
Forgot your password? / Send me a login link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.
Join The Times of Israel Community
Commenting is available for paying members of The Times of Israel Community only. Please join our Community to comment and enjoy other Community benefits.
Please use the following structure: example@domain.com
Confirm Mail
Thank you! Now check your email
You are now a member of The Times of Israel Community! We sent you an email with a login link to . Once you're set up, you can start enjoying Community benefits and commenting.
Back to top
Never miss breaking news on Israel
Get notifications to stay updated
You're subscribed
image
Register for free
and continue reading
Registering allows you to manage your newsletters and alerts and helps us improve your experience. It takes just a few seconds.
Already registered? Enter your email to sign in.
Please use the following structure: example@domain.com
Or Continue with
By registering you agree to the terms and conditions. Once registered, you’ll receive our Daily Edition email for free.
Register to continue
Or Continue with
Log in to continue
Sign in or Register
I forgot my password / Send me a sign in link
Or Continue with
check your email
Check your email
We sent an email to you at .
It has a link that will sign you in.